Preparation and properties of a drug release membrane of mitomycin C with N-succinyl-hydroxyethyl chitosan

Journal of Materials Science: Materials in Medicine

Volumn 22, Issue 12, 2011, Pages 2745-2755

  Li, Minyu ^a   Han, Baoqin ^a   Liu, Wanshun ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOABSORPTION; CHITOSAN FILM; DRUG RELEASE; EQUILIBRIUM WATER CONTENTS; FIBROBLAST PROLIFERATION; FTIR; IN-VITRO; IN-VIVO; MITOMYCIN C; PREPARATION AND PROPERTIES; SUBCUTANEOUS TISSUES; SWELLING PROPERTIES; SWELLING RATIO; THEORETICAL BASIS;

BIOCOMPATIBILITY; BIODEGRADATION; CELL CULTURE; CHITOSAN; FIBROBLASTS; MEMBRANES; SURGERY; TISSUE;

FILTRATION;

CHITOSAN; MITOMYCIN C; N SUCCINYL HYDROXYETHYL CHITOSAN; UNCLASSIFIED DRUG; ARTIFICIAL MEMBRANE; BIOMATERIAL; MITOMYCIN; N-SUCCINYL-CHITOSAN; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOSORPTION; CELL ADHESION; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RELEASE; FIBROBLAST; FILTERING OPERATION; HISTOCOMPATIBILITY; INFRARED SPECTROPHOTOMETRY; MEMBRANE PERMEABILITY; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SUBCUTANEOUS TISSUE; WATER CONTENT; ANIMAL; ARTIFICIAL MEMBRANE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG DELIVERY SYSTEM; FEMALE; INFRARED SPECTROSCOPY; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERMEABILITY; RABBIT; WISTAR RAT;

RATTUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FEMALE; FIBROBLASTS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES, ARTIFICIAL; MICE; MITOMYCIN; PERMEABILITY; RABBITS; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 84355161455     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4455-8     Document Type: Article

References (38)

1. S Resnikoff D Pascolini D Etya'ale, et al. 2004 Global data on visual impairment in the year 2002 B World Health Organ 82 844 851 (Pubitemid 39573742)
2. HA Quigley AT Broman 2006 The number of people with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 3 262 267 10.1136/bjo.2005.081224 1:STN:280:DC%2BD28%2FpvFOjsA%3D%3D (Pubitemid 43325451)
3. SK West 2000 Looking forward to 20/20: a focus on the epidemiology of eye diseases Epidemiol Rev 22 1 64 70 1:STN:280:DC%2BD3M%2FnsVSisw%3D%3D (Pubitemid 30625929)
4. JE Cairns 1968 Trabeculectomy: preliminary report of a new method Am J Ophthalmol 66 4 673 679 1:STN:280:DyaF1M3htVClsQ%3D%3D
5. NS Borisuth B Phillips T Krupin 1999 The risk profile of glaucoma filtration surgery Curr Opin Ophthalmol 10 2 112 116 10.1097/00055735-199904000- 00006 1:STN:280:DyaK1Mzgsl2huw%3D%3D (Pubitemid 29342532)
6. EM Addicks HA Quigley WR Green AL Robin 1983 Histological characteristics of filtering blebs in glaucomatous eyes Arch Ophthalmol 101 5 795 798 10.1001/archopht.1983.01040010795021 1:STN:280:DyaL3s3gtlGqsw%3D%3D (Pubitemid 13133119)
7. HD Jampel LJ McGuigan GR Dunkelberger, et al. 1988 Cellular proliferation after experimental glaucoma filtration surgery Arch Ophthalmol 106 1 89 94 10.1001/archopht.1988.01060130095036 1:STN:280:DyaL1c7gs1Squg%3D%3D (Pubitemid 18028648)
8. The Fluorouracil Filtering Surgery Study Group 1989 Fluorouracil filtering surgery study one-year follow-up Am J Ophthalmol 108 625 635
9. H Mietz GK Krieglstein 2006 Postoperative application of mitomycin c improves the complete success rate of primary trabeculectomy: a prospective, randomized trial Graefes Arch Clin Exp Opthalmol 244 11 1429 1436 10.1007/s00417-005-0217-y 1:CAS:528:DC%2BD28XhtFyltrfJ (Pubitemid 44741254)
10. MB Shields MW Scroggs CM Sloop RB Simmons 1993 Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C Am J Ophthalmol 116 6 673 683 1:STN:280: DyaK2c%2FntVyqug%3D%3D (Pubitemid 23356532)
11. EJ Higginbotham RK Stevens DC Musch KO Karp PR Lichter TJ Bergstrom GL Skuta 1996 Bleb-related endophthalmitis after trabeculectomy with mitomycin C Ophthalmology 103 4 650 656 1:STN:280:DyaK283gtVSmtA%3D%3D (Pubitemid 26114237)
12. GS Mégevand JF Salmon RP Scholtz AD Murray 1995 The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery Ophthalmology 102 1 84 90
13. AL Robin R Ramakrishnan R Krishnadas SD Smith JD Katz S Selvaraj GL Skuta R Bhatnagar 1997 A long-term dose-response study of mitomycin in glaucoma filtration surgery Arch Ophthalmol 115 8 969 974 10.1001/archopht.1997. 01100160139001 1:CAS:528:DyaK2sXls1Wlur0%3D (Pubitemid 27328484)
14. A Nagai-Kusuhara M Nakamura M Fujioka A Negi 2008 Long-term results of amniotic membrane transplantation-assisted bleb revision for leaking blebs Graefes Arch Clin Exp Ophthalmol 246 4 567 571 10.1007/s00417-007-0727-x
15. HS Chen R Ritch T Krupin WC Hsu 2006 Control of filtering bleb structure through tissue bioengineering: an animal model Invest Ophthalmol Vis Sci 47 12 5310 5314 10.1167/iovs.06-0378 (Pubitemid 46723780)
16. N Shoji K Shimizu K Takahashi R Nemoto H Kawai T Tomioka 2004 The application of crosslinked hyaluronate hydrogel to trabeculectomy J Jpn Ophthalmol 108 5 277 282
17. O Felt P Furrer JM Mayer B Plazonnet P Buri R Gurny 1999 Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention Int J Pharm 180 2 185 193 10.1016/S0378-5173(99)00003-4 1:CAS:528:DyaK1MXjsF2itrg%3D (Pubitemid 29238202)
18. PJ VandeVord HW Matthew SP DeSilva L Mayton B Wu PH Wooley 2002 Evaluation of the biocompatibility of a chitosan scaffold in mice J Biomed Mater Res 59 3 585 590 10.1002/jbm.1270 1:CAS:528:DC%2BD38Xjt1SqsQ%3D%3D (Pubitemid 34037503)
19. PK Dutta J Dutta VS Tripathi 2004 Chitin and chitosan: chemistry, properties and applications J Sci Ind Res 63 1 20 31 1:CAS:528: DC%2BD2cXhtVOgs7Y%3D (Pubitemid 38122923)
20. A Sarasam P Brown SS Khajotia JJ Dmytryk SV Madihally 2008 Antibacterial activity of chitosan-based matrices on oral pathogens J Mater Sci Mater Med 19 1083 1090 10.1007/s10856-007-3072-z 1:CAS:528:DC%2BD1cXis1Wgsrc%3D (Pubitemid 351343761)
21. T Mori M Okumura M Matsuura K Ueno S Tokura YS Minami, et al. 1997 Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro Biomaterials 18 13 947 951 10.1016/S0142-9612(97)00017-3 1:CAS:528:DyaK2sXktVCis7s%3D (Pubitemid 27270221)
22. O Felt P Buri R Gurny 1998 Chitosan: a unique polysaccharide for drug delivery Drug Dev Ind Pharm 24 11 979 993 10.3109/03639049809089942 1:CAS:528:DyaK1cXmsVanur0%3D (Pubitemid 28460237)
23. L Illum 1998 Chitosan and its use as a pharmaceutical excipient Pharm Res 15 9 1326 1331 10.1023/A:1011929016601 1:CAS:528:DyaK1cXmtFyhtbo%3D (Pubitemid 28427917)
24. R Yamaguchi Y Arai T Itoh S Hirano 1981 Preparation of partially N-Succinylated chitosans and their cross-linked gels Carbohydr Res 88 172 175 10.1016/S0008-6215(00)84614-5 1:CAS:528:DyaL3MXosVCisA%3D%3D
25. CY Yan DW Chen JW Gu HY Hu XL Zhao MX Qiao 2006 Preparation of N-Succinyl-chitosan and their physical-chemical properties as a novel excipient Pharm S J 126 9 789 793 1:CAS:528:DC%2BD28XhtFymurnP
26. Y Kato H Onishi Y Machida 2004 N-Succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates Biomaterials 25 5 907 915 10.1016/S0142-9612(03)00598-2 1:CAS:528:DC%2BD3sXoslOmsrs%3D (Pubitemid 37371998)
27. YH Song H Onishi T Nagai 1992 Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-Succinyl-chitosan and carboxymethyl-chitin Chem Pharm Bull 40 10 2822 2825 1:CAS:528: DyaK3sXhtV2msrk%3D
28. GL Miller 1959 Use of dinitrosalicylic acid reagent for determination of reducing sugar Anal Chem 31 3 426 428 10.1021/ac60147a030 1:CAS:528: DyaG1MXmtFKiuw%3D%3D
29. MGN Campos HR Rawls LH Innoc N Satsangi 2009 In vitro gentamicin sustained and controlled release from chitosan cross-linked films J Mater Sci Mater Med 20 2 537 542 10.1007/s10856-008-3611-2 1:CAS:528:DC%2BD1MXhtlSrs7c%3D
30. 1H NMR spectroscopy Polym Bull 26 87 94 10.1007/BF00299352 1:CAS:528:DyaK3MXkslaltr0%3D (Pubitemid 21682379)
31. Tam DY, Ahmed LLK. New glaucoma surgical devices. In: Grehn F, Stamper R, editors. Glaucoma. Berlin: Springer; 2009. p. 75-98.
32. H Mietz G Welsandt A Hueber C Esser GK Krieglstein 2007 Synergistic effects of combined cytotoxic and apoptosis-inducing drugs on Tenon's capsule fibroblasts in vitro and in vivo Graefes Arch Clin Exp Opthalmol 245 1367 1375 10.1007/s00417-007-0547-z 1:CAS:528:DC%2BD2sXptVGmsrk%3D (Pubitemid 47278673)
33. N Tsurumaru M Arai K Teruya J Sueda R Yamakawa 2009 Seprafilm as a new antifibrotic agent following trabeculectomy in rabbit eyes Jpn J Ophthalmol 53 164 170 10.1007/s10384-008-0638-3 1:CAS:528:DC%2BD1MXjvVWjsLc%3D
34. SS Lee P Hughes AD Ross MR Robinson 2010 Biodegradable implants for sustained drug release in the eye Pharm Res 27 10 2043 2053 10.1007/s11095-010- 0159-x 1:CAS:528:DC%2BC3cXntFGlsbo%3D
35. MNV Kumar 2000 A review of chitin and chitosan applications React Funct Polym 46 1 27 10.1016/S1381-5148(00)00038-9 1:CAS:528:DC%2BD3cXptVWrsro%3D (Pubitemid 33763425)
36. M Prabaharan 2008 Review paper: chitosan derivatives as promising materials for controlled drug delivery J Biomater Appl 23 1 5 36 10.1177/0885328208091562 1:CAS:528:DC%2BD1cXptFygtb0%3D
37. LC Wang XG Chen DY Zhong QC Xu 2007 Study on poly(vinyl alcohol)/carboxymethyl-chitosan blend film as local drug delivery system J Mater Sci Mater Med 18 1125 1133 10.1007/s10856-007-0159-5 1:CAS:528: DC%2BD2sXlsVCjsrk%3D (Pubitemid 46795231)
38. JC Vogt G Brandes I Krüger P Behrens I Nolte T Lenarz M Stieve 2008 A comparison of different nanostructured biomaterials in subcutaneous tissue J Mater Sci Mater Med 19 2629 2636 10.1007/s10856-007-3353-6 1:CAS:528: DC%2BD1cXlslWgsbo%3D